{"slideshow_credits": null, "snippet": "The deal with the biotechnology company Adaptimmune comes a little over a month after Glaxo agreed to sell its cancer drug business to the Swiss pharmaceutical maker Novartis.", "abstract": "The deal with the biotechnology company Adaptimmune comes a little over a month after Glaxo agreed to sell its cancer drug business to the Swiss pharmaceutical maker Novartis.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/06/02/glaxosmithkline-in-350-million-cancer-drug-venture/", "lead_paragraph": null, "headline": {"main": "GlaxoSmithKline in $350 Million Cancer Drug Venture", "kicker": "DealBook"}, "_id": "538c3e5438f0d806146f78d2", "word_count": "310", "multimedia": [{"height": 126, "url": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 401, "url": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-articleLarge.jpg", "legacy": {"xlarge": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "401"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/06/03/business/dbpix-GlaxoSmithKline/dbpix-GlaxoSmithKline-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-06-02T05:04:35Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "glocations", "value": "England", "rank": "1"}, {"name": "organizations", "value": "Novartis AG", "rank": "2"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "3"}, {"name": "subject", "value": "Cancer", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "4"}, {"name": "subject", "value": "Biotechnology", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}